H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure
GlaxoSmithKline plc announced that the FDA has approved its pandemic…
25 November 2013 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the FDA has approved its pandemic Influenza A Virus Monovalent Vaccine...